Literature DB >> 22323495

Mitral valve repair for severe mitral regurgitation secondary to lone atrial fibrillation.

Hunaid A Vohra1, Robert N Whistance, Ahmed Magan, Sayed A Sadeque, Steve A Livesey.   

Abstract

OBJECTIVES: Significant mitral regurgitation (MR) may arise from isolated annular dilatation secondary to lone atrial fibrillation (AF) and associated atrial remodelling. The aim of the present study is to assess the outcome of surgery for this condition.
METHODS: Between November 2007 and July 2011, 20 patients underwent mitral valve (MV) repair for severe MR secondary to AF. The median age of patients was 77.5 years (45-82 years) and the mean pre-operative duration of AF was 84.6 ± 92 months. The left ventricle was moderately (ejection fraction 30-50%; n = 6) or severely (<30%; n = 1) impaired in seven patients pre-operatively. Mean logistic EuroSCORE was 8.1 ± 5.9 and mean follow-up was 18.0 ± 12.5 months.
RESULTS: All operations were elective. Concomitant anti-arrhythmic procedures (maze procedure, pulmonary vein isolation) or left atrial (LA) appendage amputation were performed in all patients; tricuspid valve repair was undertaken in 12 patients and coronary artery bypass grafting in 2 patients. Ring annuloplasty was performed in all patients. The median ring size was 30 mm (range 24-36 mm). On-table transoesophageal echocardiography post-repair showed mild residual MR in two patients and no MR in the remainder. There were no cases of systolic anterior motion. There was one re-exploration for bleeding. No patients required haemofiltration or suffered from stroke and deep sternal wound infections. There was no in-hospital mortality. At discharge mean left ventricular (LV) end-diastolic diameter was 4.8 ± 0.7 cm compared with 5.6 ± 0.7 cm pre-operatively (P < 0.005), while mean LV end-systolic diameter was 3.2 ± 0.8 cm when compared with 4.0 ± 0.7 cm pre-operatively (P < 0.005). The mean LA size was 5.2 ± 1.0 cm when compared with 6.1 ± 1.6 cm pre-operatively (P = 0.03). There was mild MR in two patients, but none in the rest. The mean MV area was 3.0 ± 0.7 cm(2). The mean systolic pulmonary artery pressure was 40.4 ± 15.5 mmHg when compared with 54.1 ± 12.2 mmHg pre-operatively (P = 0.02). Seventeen patients (85%) were in NYHA class I/II at latest follow-up (P < 0.0001 vs pre-operatively). During follow-up, there were no thrombo-embolic complications, re-operation, endocarditis or deaths.
CONCLUSIONS: MV annuloplasty for annular dilatation secondary to AF has a good mid-term outcome.

Entities:  

Mesh:

Year:  2012        PMID: 22323495     DOI: 10.1093/ejcts/ezs029

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

Review 1.  Functional mitral regurgitation, updated: ventricular or atrial?

Authors:  Yukio Abe; Yosuke Takahashi; Toshihiko Shibata
Journal:  J Echocardiogr       Date:  2019-11-14

2.  Clinically unrecognized mitral regurgitation is prevalent in lone atrial fibrillation.

Authors:  Sanjiv Sharma; Joel Lardizabal; Mark Monterroso; Neil Bhambi; Rohan Sharma; Rasham Sandhu; Sarabjeet Singh
Journal:  World J Cardiol       Date:  2012-05-26

3.  Quantitative analysis of mitral valve morphology in atrial functional mitral regurgitation using real-time 3-dimensional echocardiography atrial functional mitral regurgitation.

Authors:  Tao Cong; Jinping Gu; Alex Pui-Wai Lee; Zhijuan Shang; Yinghui Sun; Qiaobing Sun; Hong Wei; Na Chen; Siyao Sun; Tingting Fu
Journal:  Cardiovasc Ultrasound       Date:  2018-08-21       Impact factor: 2.062

4.  Mitral valve repair and surgical ablation for atrial functional mitral regurgitation.

Authors:  Jinmiao Chen; Yulin Wang; Minzhi Lv; Zhaohua Yang; Shijie Zhu; Lai Wei; Tao Hong; Wenjun Ding; Yi Lin; Chunsheng Wang
Journal:  Ann Transl Med       Date:  2020-11

5.  Prognostic comparison of atrial and ventricular functional mitral regurgitation.

Authors:  Chisato Okamoto; Atsushi Okada; Kunihiro Nishimura; Kenji Moriuchi; Masashi Amano; Hiroyuki Takahama; Makoto Amaki; Takuya Hasegawa; Hideaki Kanzaki; Tomoyuki Fujita; Junjiro Kobayashi; Satoshi Yasuda; Chisato Izumi
Journal:  Open Heart       Date:  2021-02

6.  Mitral valve surgery for atrial functional mitral regurgitation: predicting recurrent mitral regurgitation and mid-term outcome.

Authors:  Naonori Kawamoto; Satsuki Fukushima; Satoshi Kainuma; Ayumi Ikuta; Naoki Tadokoro; Takashi Kakuta; Tomoyuki Fujita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-03-03

7.  Midterm results of mitral valve repair for atrial functional mitral regurgitation: a retrospective study.

Authors:  Daisuke Kaneyuki; Hiroyuki Nakajima; Toshihisa Asakura; Akihiro Yoshitake; Chiho Tokunaga; Masato Tochii; Jun Hayashi; Akitoshi Takazawa; Hiroaki Izumida; Atsushi Iguchi
Journal:  J Cardiothorac Surg       Date:  2020-10-12       Impact factor: 1.637

8.  Efficacy of left atrial plication for atrial functional mitral regurgitation.

Authors:  Masamichi Matsumori; Motoharu Kawashima; Takamitsu Aihara; Jun Fujisue; Masato Fujimoto; Keigo Fukase; Yoshikatsu Nomura; Hiroshi Tanaka; Hirohisa Murakami; Nobuhiko Mukohara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2020-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.